Patients with monoclonal gammopathy of undetermined signfiance (MGUS) and smoldering multiple myeloma (SMM) in the former group had lower difference between involved and uninvolved FLCs (dFLC), higher M-protein, and lower rates of t(11;14) at AL diagnosis. This evidence concerns the gene MYOM2 and plasma cell myeloma.